Ibex Medical Analytics, a Tel Aviv, Israel-based AI-powered cancer diagnostics company, raised $10M in debt funding.
The round was led by Kreos Capital.
The company intends to use the funds to strengthen and expand its US team and support new customer deployments, accelerating further business growth and R&D initiatives.
Led by CEO Joseph Mossel, Ibex Medical Analytics provides clinical grade AI-powered solutions, empowering physicians to provide accurate, timely and personalized cancer diagnosis for every patient. Its Galen suite of solutions is used as part of everyday routine, supporting pathologists and providers worldwide in improving the quality and accuracy of diagnosis, and implementing comprehensive quality control. Ibex’s Artificial Intelligence technology is built on Deep Learning algorithms trained by a team of pathologists, data scientists and software engineers.
FinSMEs
10/11/2022